1. Home
  2. ULCC vs NEO Comparison

ULCC vs NEO Comparison

Compare ULCC & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Frontier Group Holdings Inc.

ULCC

Frontier Group Holdings Inc.

HOLD

Current Price

$4.90

Market Cap

1.1B

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$11.77

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULCC
NEO
Founded
1994
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2021
1999

Fundamental Metrics

Financial Performance
Metric
ULCC
NEO
Price
$4.90
$11.77
Analyst Decision
Hold
Buy
Analyst Count
10
9
Target Price
$5.56
$11.38
AVG Volume (30 Days)
5.1M
1.7M
Earning Date
02-06-2026
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,729,000,000.00
$709,162,000.00
Revenue This Year
$0.37
$10.90
Revenue Next Year
$14.59
$9.88
P/E Ratio
N/A
N/A
Revenue Growth
1.77
10.10
52 Week Low
$2.89
$4.72
52 Week High
$10.26
$19.12

Technical Indicators

Market Signals
Indicator
ULCC
NEO
Relative Strength Index (RSI) 50.71 57.42
Support Level $4.89 $11.46
Resistance Level $5.57 $12.19
Average True Range (ATR) 0.36 0.37
MACD -0.06 -0.11
Stochastic Oscillator 25.00 38.13

Price Performance

Historical Comparison
ULCC
NEO

About ULCC Frontier Group Holdings Inc.

Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. Majority of revenue is from Domestic flight follow by International.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: